Tomophase Overview
- Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
Tomophase General Information
Description
Developer of opto-medical devices. The company is focused on the development and commercialization of its patented technology for minimally invasive opto-medical devices.
Contact Information
Website
www.tomophase.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Parent Company
Winstar Medical Science Company
Primary Office
- 1 Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
+1 (347) 000-0000
Tomophase Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 18-Apr-2014 | 00.00 | Completed | Generating Revenue | ||
| 2. Secondary Transaction - Private | 00.00 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 23-Nov-2005 | $4.5M | $4.5M | Completed | Generating Revenue |
Tomophase Patents
Tomophase Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20110029049-A1 | Image-guided thermotherapy based on selective tissue thermal treatment | Active | 29-Apr-2009 | 00000000000 | |
| US-20130282083-A1 | Image-guided thermotherapy based on selective tissue thermal treatment | Inactive | 29-Apr-2009 | 00000000000 | |
| US-8467858-B2 | Image-guided thermotherapy based on selective tissue thermal treatment | Active | 29-Apr-2009 | 00000000000 | 000 |
| CA-2528417-A1 | Measurements of optical inhomogeneity and other properties in substances using propagation modes of light | Active | 04-Jun-2003 | 0000000000 | |
| CA-2528417-C | Measurements of optical inhomogeneity and other properties in substances using propagation modes of light | Active | 04-Jun-2003 | A61B5/0059 |
Tomophase Executive Team (7)
Tomophase Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Peter Norris | Tomophase | Chief Executive Officer, Executive Chairman & Co-Founder | 000 0000 |
Tomophase Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Tomophase Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| MassVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Sanderling Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |